GEODE CAPITAL MANAGEMENT, LLC - BSB BANCORP INC MD ownership

BSB BANCORP INC MD's ticker is BLMT and the CUSIP is 05573H108. A total of 56 filers reported holding BSB BANCORP INC MD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BSB BANCORP INC MD
ValueSharesWeighting
Q4 2018$5,178,000
+127.5%
184,594
+164.4%
0.00%0.0%
Q3 2018$2,276,000
-1.1%
69,824
+4.3%
0.00%0.0%
Q2 2018$2,301,000
+20.9%
66,917
+7.6%
0.00%0.0%
Q1 2018$1,903,000
+6.2%
62,199
+1.5%
0.00%0.0%
Q4 2017$1,792,000
-1.1%
61,282
+1.3%
0.00%0.0%
Q3 2017$1,812,000
+5.8%
60,513
+3.3%
0.00%0.0%
Q2 2017$1,713,000
+9.5%
58,581
+5.8%
0.00%0.0%
Q1 2017$1,564,000
+0.2%
55,384
+2.7%
0.00%0.0%
Q4 2016$1,561,000
+21.5%
53,934
-1.7%
0.00%0.0%
Q3 2016$1,285,000
+7.9%
54,864
+4.3%
0.00%0.0%
Q2 2016$1,191,000
+1.9%
52,593
+1.1%
0.00%0.0%
Q1 2016$1,169,000
+0.2%
52,033
+4.2%
0.00%0.0%
Q4 2015$1,167,000
+10.1%
49,933
-0.5%
0.00%0.0%
Q3 2015$1,060,000
-0.3%
50,183
+4.2%
0.00%0.0%
Q2 2015$1,063,000
+51.6%
48,144
+35.8%
0.00%
Q1 2015$701,000
+9.7%
35,447
+3.2%
0.00%
Q4 2014$639,000
-1.7%
34,344
-2.7%
0.00%
Q3 2014$650,000
-10.8%
35,289
-17.1%
0.00%
Q2 2014$729,000
+18.7%
42,547
+19.1%
0.00%
Q1 2014$614,000
+49.0%
35,738
+30.7%
0.00%
Q4 2013$412,000
+7.6%
27,3370.0%0.00%
Q3 2013$383,000
+6.7%
27,3370.0%0.00%
Q2 2013$359,00027,3370.00%
Other shareholders
BSB BANCORP INC MD shareholders Q2 2017
NameSharesValueWeighting ↓
Clover Partners, L.P. 56,179$1,719,0001.92%
BANC FUNDS CO LLC 929,460$28,441,0001.46%
FJ Capital Management LLC 409,900$10,153,0001.25%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 198,362$6,070,0000.54%
Ativo Capital Management LLC 31,009$949,0000.27%
PECAUT & CO. 6,542$200,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 7,800$239,0000.12%
PROSPECTOR PARTNERS LLC 21,280$651,0000.10%
BEESE FULMER INVESTMENT MANAGEMENT, INC. 6,544$200,0000.04%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 470,055$14,383,0000.02%
View complete list of BSB BANCORP INC MD shareholders